US job openings in research and development are plunging as the Trump administration ramps up funding cuts to government ...

US job openings in research and development are plunging as the Trump administration ramps up funding cuts to government ...

MELBOURNE, Australia, May 20, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix", "the Company") today announces a strong presence at the 55th Annual Scientific Meeting ...

Merck & Co. is undervalued with strong oncology growth, key R&D investments, and shareholder returns. Click here to read an ...

It's been a sad week for thyssenkrupp nucera AG & Co. KGaA (ETR:NCH2), who've watched their investment drop 12% to €8.73 in the week since the company reported its second-quarter result.

In an interview with CNBC at this week's Davos World Economic Forum, Merck KGaA’s CEO Stefan Oschman said that he is “absolutely certain” that a pharma company ranked among the 50 largest in ...

Merck KGaA is doubling down on AI through a new collaboration agreement with tech firm Iktos, using its generative modelling technology to speed up the discovery and design of promising new compounds.

Universal Display appears reasonably valued, and its prospects have improved after its recent blue OLED breakthrough. Read ...

Trump has claimed the move could cut US drug prices by 30 to 80 percent. However, according to German consultancy ...

(Bloomberg) -- One thing is clear as the first-quarter earnings season draws to a close: The uncertain outlook for the global economy is superseding better-than-feared results even as stocks rally ...

Merck KGaA's recent stock dip of 13% might scream trouble, but under the hood, things look remarkably solid. Despite a ...